Blackrock Health Sciences Etf EBITDA
| BME Etf | USD 38.66 0.31 0.81% |
BlackRock Health Sciences fundamentals help investors to digest information that contributes to BlackRock Health's financial success or failures. It also enables traders to predict the movement of BlackRock Etf. The fundamental analysis module provides a way to measure BlackRock Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BlackRock Health etf.
BlackRock |
BlackRock Health Sciences ETF EBITDA Analysis
BlackRock Health's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current BlackRock Health EBITDA | 20.02 M |
Most of BlackRock Health's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BlackRock Health Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, BlackRock Health Sciences reported earnings before interest,tax, depreciation and amortization of 20.02 M. This is much higher than that of the Capital Markets family and significantly higher than that of the Financials category. The ebitda for all United States etfs is notably lower than that of the firm.
BlackRock EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BlackRock Health's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of BlackRock Health could also be used in its relative valuation, which is a method of valuing BlackRock Health by comparing valuation metrics of similar companies.BlackRock Health is currently under evaluation in ebitda as compared to similar ETFs.
BlackRock Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, BlackRock Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BlackRock Health's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
BlackRock Fundamentals
| Return On Equity | 0.0901 | ||||
| Return On Asset | 0.0017 | ||||
| Profit Margin | 6.84 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 542.61 M | ||||
| Shares Outstanding | 13.6 M | ||||
| Shares Owned By Institutions | 23.04 % | ||||
| Number Of Shares Shorted | 8.01 K | ||||
| Price To Earning | 6.69 X | ||||
| Price To Book | 0.86 X | ||||
| Price To Sales | 66.08 X | ||||
| Revenue | 8.19 M | ||||
| Gross Profit | 7.73 M | ||||
| EBITDA | 20.02 M | ||||
| Net Income | 20.02 M | ||||
| Cash And Equivalents | 16.68 K | ||||
| Total Debt | 60.69 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 0.36 X | ||||
| Book Value Per Share | 44.20 X | ||||
| Cash Flow From Operations | 4.76 M | ||||
| Short Ratio | 0.26 X | ||||
| Earnings Per Share | 3.93 X | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 528.05 M | ||||
| Total Asset | 596.1 M | ||||
| Retained Earnings | 170.52 M | ||||
| Annual Yield | 0.07 % | ||||
| Five Year Return | 5.86 % | ||||
| Net Asset | 596.1 M | ||||
| Last Dividend Paid | 2.56 |
About BlackRock Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BlackRock Health Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BlackRock Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BlackRock Health Sciences based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BlackRock Etf
BlackRock Health financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Health security.